Ivermectin
(right click,save link as to download,it is a temp file,please download as soon as possible, you can also use CTRL+S to save the whole html page)
Basic Info
| Common Name | Ivermectin(F05659) |
| 2D Structure | |
| FRCD ID | F05659 |
| CAS Number | 70161-11-4 |
| PubChem CID | 6321424 |
| Formula | C48H74O14 |
| IUPAC Name | None |
| InChI Key | AZSNMRSAGSSBNP-XPNPUAGNSA-N |
| InChI | InChI=1S/C48H74O14/c1-11-25(2)43-28(5)17-18-47(62-43)23-34-20-33(61-47)16-15-27(4)42(26(3)13-12-14-32-24-55-45-40(49)29(6)19-35(46(51)58-34)48(32,45)52)59-39-22-37(54-10)44(31(8)57-39)60-38-21-36(53-9)41(50)30(7)56-38/h12-15,19,25-26,28,30-31,33-45,49-50,52H,11,16-18,20-24H2,1-10H3/b13-12+,27-15+,32-14+/t25-,26-,28-,30-,31-,33+,34-,35-,36-,37-,38-,39-,40+,41-,42-,43+,44-,45+,47+,48+/m0/s1 |
| Canonical SMILES | CCC(C)C1C(CCC2(O1)CC3CC(O2)CC=C(C(C(C=CC=C4COC5C4(C(C=C(C5O)C)C(=O)O3)O)C)OC6CC(C(C(O6)C)OC7CC(C(C(O7)C)O)OC)OC)C)C |
| Isomeric SMILES | CC[C@H](C)[C@@H]1[C@H](CC[C@@]2(O1)C[C@@H]3C[C@H](O2)C/C=C(/[C@H]([C@H](/C=C/C=C/4\CO[C@H]5[C@@]4([C@@H](C=C([C@H]5O)C)C(=O)O3)O)C)O[C@H]6C[C@@H]([C@H]([C@@H](O6)C)O[C@H]7C[C@@H]([C@H]([C@@H](O7)C)O)OC)OC)\C)C |
| Synonyms |
IVERMECTIN
Ivermectin B1a
Dihydroavermectin B1a
70288-86-7
22,23-Dihydroavermectin B1a
71827-03-7
avermectin H2B1a
UNII-91Y2202OUW
70161-11-4
CHEBI:63941
|
| Classifies |
Veterinary Drug
|
| Update Date | Nov 13, 2018 17:07 |
Chemical Taxonomy
| Kingdom | Organic compounds |
| Superclass | Phenylpropanoids and polyketides |
| Class | Macrolides and analogues |
| Subclass | Milbemycins |
| Intermediate Tree Nodes | Not available |
| Direct Parent | Milbemycins |
| Alternative Parents | |
| Molecular Framework | Aliphatic heteropolycyclic compounds |
| Substituents | Milbemycin - Disaccharide - Glycosyl compound - O-glycosyl compound - Ketal - Oxane - Tetrahydrofuran - Tertiary alcohol - Carboxylic acid ester - Lactone - Secondary alcohol - Acetal - Carboxylic acid derivative - Dialkyl ether - Ether - Oxacycle - Organoheterocyclic compound - Monocarboxylic acid or derivatives - Organic oxide - Carbonyl group - Hydrocarbon derivative - Alcohol - Organic oxygen compound - Organooxygen compound - Aliphatic heteropolycyclic compound |
| Description | This compound belongs to the class of organic compounds known as milbemycins. These are a group of macrolides with a structure containing a 16-membered lactone ring fused to a 1,7-dioxaspiroundecane ring system and to either a benzofuran (or hydrogenated derivative thereof). In some cases (e.g. Milbemycin E), the tetrahydrofuranyl ring is missing. Milbemycins can be o-glycosylated at C13 to form Avermectins. Milbemycins are produced by Streptomyces species. |
Properties
| Property Name | Property Value |
|---|---|
| Molecular Weight | 875.106 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 14 |
| Rotatable Bond Count | 8 |
| Complexity | 1680 |
| Monoisotopic Mass | 874.508 |
| Exact Mass | 874.508 |
| XLogP | 4.1 |
| Formal Charge | 0 |
| Heavy Atom Count | 62 |
| Defined Atom Stereocenter Count | 20 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 3 |
| Undefined Bond Stereocenter Count | 0 |
| Isotope Atom Count | 0 |
| Covalently-Bonded Unit Count | 1 |
ADMET
| Model | Result | Probability |
|---|---|---|
| Absorption | ||
| Blood-Brain Barrier | BBB+ | 0.5745 |
| Human Intestinal Absorption | HIA+ | 0.9050 |
| Caco-2 Permeability | Caco2- | 0.7613 |
| P-glycoprotein Substrate | Substrate | 0.8316 |
| P-glycoprotein Inhibitor | Inhibitor | 0.7066 |
| Inhibitor | 0.7394 | |
| Renal Organic Cation Transporter | Non-inhibitor | 0.7382 |
| Distribution | ||
| Subcellular localization | Mitochondria | 0.8053 |
| Metabolism | ||
| CYP450 2C9 Substrate | Non-substrate | 0.8800 |
| CYP450 2D6 Substrate | Non-substrate | 0.8855 |
| CYP450 3A4 Substrate | Substrate | 0.7739 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.9045 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9071 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9231 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9025 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8309 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.6859 |
| Excretion | ||
| Toxicity | ||
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9533 |
| Non-inhibitor | 0.5055 | |
| AMES Toxicity | Non AMES toxic | 0.8174 |
| Carcinogens | Non-carcinogens | 0.9709 |
| Fish Toxicity | High FHMT | 0.9237 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9989 |
| Honey Bee Toxicity | High HBT | 0.8752 |
| Biodegradation | Not ready biodegradable | 0.9584 |
| Acute Oral Toxicity | III | 0.4494 |
| Carcinogenicity (Three-class) | Non-required | 0.5219 |
| Model | Value | Unit |
|---|---|---|
| Absorption | ||
| Aqueous solubility | -4.2367 | LogS |
| Caco-2 Permeability | 0.5354 | LogPapp, cm/s |
| Distribution | ||
| Metabolism | ||
| Excretion | ||
| Toxicity | ||
| Rat Acute Toxicity | 3.5130 | LD50, mol/kg |
| Fish Toxicity | 0.5638 | pLC50, mg/L |
| Tetrahymena Pyriformis Toxicity | 1.1327 | pIGC50, ug/L |
MRLs
| Food | Product Code | Country | MRLs | Application Date | Notes |
|---|---|---|---|---|---|
| Muscle Of Cattle | United States | 10ppb | |||
| Muscle Of Swine | United States | 20ppb | |||
| Liver Of American Bison | United States | 15ppb | |||
| Liver Of Reindeer | United States | 15ppb | |||
| Liver Of Sheep | United States | 30ppb | |||
| Liver Of Swine | United States | 20ppb | |||
| Liver Of Cattle | United States | 100ppb | |||
| Other Poultry Animals,Edible Offal | Japan | 0.02ppm | |||
| Chicken,Edible Offal | Japan | 0.02ppm | |||
| Other Poultry Animals,Kidney | Japan | 0.02ppm | |||
| Chicken,Kidney | Japan | 0.02ppm | |||
| Other Poultry Animals,Liver | Japan | 0.02ppm | |||
| Chicken,Liver | Japan | 0.02ppm | |||
| Other Poultry Animals,Fat | Japan | 0.02ppm | |||
| Chicken,Fat | Japan | 0.02ppm | |||
| Other Poultry Animals,Muscle | Japan | 0.01ppm | |||
| Chicken,Muscle | Japan | 0.01ppm | |||
| Milk | Japan | 0.01ppm | |||
| Horse,Edible Offal | Japan | 0.01ppm | |||
| Sheep,Edible Offal | Japan | 0.01ppm |
References
| Title | Journal | Date | Pubmed ID |
|---|---|---|---|
| Pipette-tip solid-phase extraction using polypyrrole as efficient adsorbent forextraction of avermectins and milbemycins in milk. | Anal Bioanal Chem | 2018 May | 29607449 |
| Plasma dispositions and concentrations of ivermectin in eggs following treatment of laying hens. | N Z Vet J | 2018 May | 29378154 |
| Preparation and Characterization of Controlled-Release Avermectin/Castor Oil-Based Polyurethane Nanoemulsions. | J Agric Food Chem | 2018 Jul 5 | 28562041 |
| Effects of the Antiparasitic Drug Moxidectin in Cattle Dung on Zooplankton and Benthic Invertebrates and its Accumulation in a Water-Sediment System. | Arch Environ Contam Toxicol | 2018 Aug | 29846763 |
| Residue depletion of ivermectin in broiler poultry. | Food Addit Contam Part A Chem Anal Control Expo Risk Assess | 2017Apr | 28067137 |
| Relationship between ivermectin concentrations at the injection site, muscle and fat of steers treated with traditional and long-acting preparations. | Food Chem Toxicol | 2017 Jul | 28479392 |
| Caprine ovarian follicle requirements differ between preantral and early antralstages after IVC in medium supplemented with GH and VEGF alone or in combination. | Theriogenology | 2017 Jan 1 | 27729112 |
| P-glycoproteins play a role in ivermectin resistance in cyathostomins. | Int J Parasitol Drugs Drug Resist | 2017 Dec | 29121562 |
| The development of an ivermectin-based attractive toxic sugar bait (ATSB) to target Anopheles arabiensis. | Malar J | 2017 Aug 15 | 28810866 |
| Accelerated follicle growth during the culture of isolated caprine preantralfollicles is detrimental to follicular survival and oocyte meiotic resumption. | Theriogenology | 2016 Oct 1 | 27371972 |
| Multiresidue method for simultaneous analysis of aflatoxin M1, avermectins, organophosphate pesticides and milbemycin in milk by ultra-performance liquid chromatography coupled to tandem mass spectrometry. | Food Addit Contam Part A Chem Anal Control Expo Risk Assess | 2016 Jun | 27144891 |
| Eco-toxicological effects of the avermectin family with a focus on abamectin and ivermectin. | Chemosphere | 2016 Jul | 27058912 |
| The physiological consequences of ingesting a toxic plant (Diplotaxis tenuifolia) influence subsequent foraging decisions by sheep (Ovis aries). | Physiol Behav | 2016 Dec 1 | 27650920 |
| Comparative plasma and milk dispositions, faecal excretion and efficacy of per osivermectin and pour-on eprinomectin in horses. | J Vet Pharmacol Ther | 2016 Dec | 27016093 |
| Oral delivery of ivermectin using a fast dissolving oral film: Implications forrepurposing ivermectin as a pharmacotherapy for alcohol use disorder. | Alcohol | 2015 Sep | 26095588 |
| Surveillance at the molecular level: Developing an integrated network fordetecting variation in avian influenza viruses in Indonesia. | Prev Vet Med | 2015 Jun 1 | 25772529 |
| Effect of high fat intake on the pharmacokinetic profile of ivermectin inrabbits. | Drug Metab Pharmacokinet | 2015 Jun | 25887422 |
| Ivermectin Pharmacokinetics, Metabolism, and Tissue/Egg Residue Profiles inLaying Hens. | J Agric Food Chem | 2015 Dec 2 | 26553292 |
| Anthelmintic resistance in gastrointestinal nematodes from grazing beef cattle inCampeche State, Mexico. | Trop Anim Health Prod | 2015 Aug | 25876195 |
| Multiday administration of ivermectin is effective in reducing alcohol intake in mice at doses shown to be safe in humans. | Neuroreport | 2014 Sep 10 | 25004078 |